TABLE 2.
References | Instr. | f (MHz) | Method | # of λ | [Hb] (μM) | [HbO2] (μM) | [HbT] (μM) | StO2 (%) | Age |
Watzman et al., 2000 | NIM | 200 | SD: 3 or 4 cm | 3 | – | – | – | 73 | 0–6 years |
Zhao et al., 2005 | Own | 140 | SD: 4 cm | 2 | 16 | 24 | 40 | 59 | 1–17 days |
Franceschini et al., 2007 | ISS | 110 | MD: 1–2.5 cm | 7 | 17 | 35 | 52 | 67 | 1 week |
14 | 19 | 33 | 57 | 6 weeks | |||||
21 | 32 | 53 | 61 | 12 weeks | |||||
24 | 49 | 73 | 67 | 52 weeks | |||||
Grant et al., 2009 | ISS | 110 | MD: 1–2.5 cm | 7 | 21 | 39 | 60 | 65 | 0–15 days |
Roche-Labarbe et al., 2010 | ISS | 110 | MD: 1–2.5 cm | 6 | 12 | 28 | 40 | 70 | 1 week |
12 | 18 | 30 | 60 | 6 weeks | |||||
Roche-Labarbe et al., 2012 | ISS | 110 | MD: 1–2.5 cm | 6 | 15 | 40 | 55 | 73 | 1 week |
15 | 28 | 43 | 65 | 10 weeks | |||||
Lin et al., 2013b | ISS | 110 | MD: 1–2.5 or 1.5–3 cm | 6 | 19 | 41 | 60 | 69 | 3.6 ± 1.7 weeks |
Dehaes et al., 2014 | ISS | 110 | MD: 1–2.5 cm | 6 | 17 | 45 | 62 | 72 | 0–4 days |
Demel et al., 2014b | ISS | 110 | MD: 1.5–3 cm | 2 | 15 | 23 | 38 | 60 | 2 days |
Dehaes et al., 2015 | ISS | 110 | MD: 1.5–3 cm | 6 | 16 | 35 | 51 | 69 | 33–71 h |
Demel et al., 2015 | ISS | 110 | MD: 1.5–3 cm | 2 | 15 | 24 | 39 | 62 | 7–71 h (preterm) |
18 | 30 | 48 | 63 | 7–54 h (term) | |||||
Lin P. Y. et al., 2016 | ISS | 110 | MD: 1–2.5 cm | 6 | – | – | – | 50–70 | 3–14 weeks (preterm) |
Farzam et al., 2017 | ISS | 110 | MD: 1.5–3 cm | 8 | 19 | 41 | 60 | 69 | 2.4 ± 0.8 days (males) |
16 | 33 | 50 | 65 | 2.6 ± 1.5 days (females) | |||||
Ferradal et al., 2017 | ISS | 110 | MD: 1.5–3 cm | 8 | 26 | 40 | 66 | 60 | ∼4 days (anesthesia) |
Schwarz et al., 2018 | ISS | 110 | MD: 1.5-3 cm | 2 | – | – | – | 54 | 4–13 days |
Instr., Instrument; NIM, NIM (Near Infrared Monitoring), Inc. (Philadelphia, PA, United States); ISS, ISS, Inc. (Champaign, IL, United States); SD, single distance; MD, multi distance.